In our study, four annotated differential metabolites related to both NRP-1 knockdown and SSd treatment were observed to have the same trend during an intervention, which suggested that the combined action of those metabolites contributed to the advanced anti-hepatoma effect. Here, NRP1 is linked to hepatocellular carcinoma.